Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:1296-1300
Published online before print March 30, 2006, doi: 10.1161/01.STR.0000217262.03192.d4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/5/1296    most recent
01.STR.0000217262.03192.d4v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weise, J.
Right arrow Articles by Bähr, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weise, J.
Right arrow Articles by Bähr, M.
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis

(Stroke. 2006;37:1296.)
© 2006 American Heart Association, Inc.


Original Contributions

Deletion of Cellular Prion Protein Results in Reduced Akt Activation, Enhanced Postischemic Caspase-3 Activation, and Exacerbation of Ischemic Brain Injury

Jens Weise, MD; Raoul Sandau, MD; Sönke Schwarting, MD; Olaf Crome, MD; Arne Wrede, MD; Walter Schulz-Schaeffer, MD; Inga Zerr, MD Mathias Bähr, MD

From the Departments of Neurology (J.W., R.S., S.S., O.C., I.Z., M.B.) and Neuropathology (A.W., W.S.-S.), University of Goettingen Medical School, Germany.

Correspondence to Jens Weise, MD, Department of Neurology, University of Goettingen Medical School, Robert-Koch-Str. 40, 37075 Goettingen, Germany. E-mail jweise{at}gwdg.de

Background and Purpose— The physiological function of cellular prion protein (PrPc) is not yet understood. Recent findings suggest that PrPc may have neuroprotective properties, and its absence increases susceptibility to neuronal injury. The purpose of this study was to elucidate the role of PrPc in ischemic brain injury in vivo.

Methods— PrP knockout (Prnp0/0) and Prnp+/+ wild-type (WT) mice were subjected to 60-minute transient or permanent focal cerebral ischemia followed by infarct volume analysis 24 hours after lesion. To identify effects of PrPc deletion on mechanisms regulating ischemic cell death, expression analysis of several proapoptotic and antiapoptotic proteins was performed at 6 and 24 hours after transient ischemia and in nonischemic controls using Western blot or immunohistochemistry.

Results— Prnp0/0 mice displayed significantly increased infarct volumes after both transient or permanent ischemia when compared with WT animals (70.2±23 versus 13.3±4 mm3; 119.8±24 versus 86.4±25 mm3). Expression of phospho-Akt (Ser473) was significantly reduced in Prnp0/0 compared with WT animals both early after ischemia and in sham controls. Furthermore, postischemic caspase-3 activation was significantly enhanced in the basal ganglia and the parietal cortex of Prnp0/0 mice. In contrast, expression of total Akt, Bax, and Bcl-2 did not differ between both groups.

Conclusions— These results demonstrate that PrPc deletion impairs the antiapoptotic phosphatidylinositol 3-kinase/Akt pathway by resulting in reduced postischemic phospho-Akt expression, followed by enhanced postischemic caspase-3 activation, and aggravated neuronal injury after transient and permanent cerebral ischemia.


Key Words: caspases • cerebral ischemia • PrPc proteins • signal transduction




This article has been cited by other articles:


Home page
JCBHome page
H. Khosravani, Y. Zhang, S. Tsutsui, S. Hameed, C. Altier, J. Hamid, L. Chen, M. Villemaire, Z. Ali, F. R. Jirik, et al.
Prion protein attenuates excitotoxicity by inhibiting NMDA receptors
J. Cell Biol., October 14, 2008; 181(3): 551 - 565.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Tsutsui, J. N. Hahn, T. A. Johnson, Z. Ali, and F. R. Jirik
Absence of the Cellular Prion Protein Exacerbates and Prolongs Neuroinflammation in Experimental Autoimmune Encephalomyelitis
Am. J. Pathol., October 1, 2008; 173(4): 1029 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. Linden, V. R. Martins, M. A. M. Prado, M. Cammarota, I. Izquierdo, and R. R. Brentani
Physiology of the Prion Protein
Physiol Rev, April 1, 2008; 88(2): 673 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K.-J. Lee, A. Panzera, D. Rogawski, L. E. Greene, and E. Eisenberg
Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation
J. Cell Sci., August 1, 2007; 120(15): 2663 - 2671.
[Abstract] [Full Text] [PDF]